Elevated levels of this cytokine have been identified in CTCL patients and show a negative correlation with prognosis, as it may cooperate with vascular endothelial growth factor and leukotriene alpha to induce endothelial cell proliferation and neovascularization [44]. The gene discussed is VEGFA; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.